Mepolizumab Significantly Improves Health Status and Asthma Control in Severe Eosinophilic Asthma: The Musca Study - a Phase IIIb Randomized, Placebo-Controlled Trial

Methods MUSCA was a Phase IIIb, placebo-controlled, randomized, double-blind, parallel-group, multicenter study (200862/NCT02281318) in patients with SEA and a history of >=2 exacerbations in the previous year despite regular high-dose inhaled glucocorticoids plus other controller(s).

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB380-AB380
Main Authors: Chupp, Geoffrey L., Prof, Bradford, Eric S., Dr, Albers, Frank C., Dr, Bratton, Daniel J., Dr, Wang-Jairaj, Jie, Dr, Nelsen, Linda M., Ms, Trevor, Jennifer L., Prof, Magnan, Antoine, Prof, ten Brinke, Anneke, Dr
Format: Article
Language:English
Subjects:
Allergy and Immunology
Asthma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods MUSCA was a Phase IIIb, placebo-controlled, randomized, double-blind, parallel-group, multicenter study (200862/NCT02281318) in patients with SEA and a history of >=2 exacerbations in the previous year despite regular high-dose inhaled glucocorticoids plus other controller(s).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.911